The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
Abstract
Importance: Among all US women, breast cancer is the second most common cancer and the second most common cause of cancer death. In 2023, an estimated 43 170 women died of breast cancer. Non-Hispanic White women have the highest incidence of breast cancer and non-Hispanic Black women have the highest mortality rate. Objective: The USPSTF commissioned a systematic review to evaluate the comparative effectiveness of different mammography-based breast cancer screening strategies by age to start and stop screening, screening interval, modality, use of supplemental imaging, or personalization of screening for breast cancer on the incidence of and progression to advanced breast cancer, breast cancer morbidity, and breast cancer–specific or all-cause mortality, and collaborative modeling studies to complement the evidence from the review. Population: Cisgender women and all other persons assigned female at birth aged 40 years or older at average risk of breast cancer. Evidence Assessment: The USPSTF concludes with moderate certainty that biennial screening mammography in women aged 40 to 74 years has a moderate net benefit. The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of screening mammography in women 75 years or older and the balance of benefits and harms of supplemental screening for breast cancer with breast ultrasound or magnetic resonance imaging (MRI), regardless of breast density. Recommendation: The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening mammography in women 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or MRI in women identified to have dense breasts on an otherwise negative screening mammogram. (I statement)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural racism and health inequities in the USA: evidence and interventions
Bailey, Z. D., Krieger, N., Agénor, M., Graves, J., Linos, N., & Bassett, M. T. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30569-x · Cited by 5,203
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
American Academy of Family Physicians
(1966) · New England Journal of Medicine · doi:10.1056/nejm196611172752014 · Cited by 1,948
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Understanding associations among race, socioeconomic status, and health: Patterns and prospects.
Williams, D. R., Priest, N., & Anderson, N. B. (2016) · Health Psychology · doi:10.1037/hea0000242 · Cited by 1,147
Cancer health disparities in racial/ethnic minorities in the United States
Zavala, V. A., Bracci, P. M., Carethers, J. M., Carvajal-Carmona, L., Coggins, N. B., Cruz-Correa, M. R., Davis, M., de Smith, A. J., Dutil, J., Figueiredo, J. C., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01038-6 · Cited by 912
Ciatto, S., Houssami, N., Bernardi, D., Caumo, F., Pellegrini, M., Brunelli, S., Tuttobene, P., Bricolo, P., Fantò, C., Valentini, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70134-7 · Cited by 838
The National Institute on Minority Health and Health Disparities Research Framework
Alvidrez, J., Castille, D., Laude-Sharp, M., Rosario, A., & Tabor, D. (2019) · American Journal of Public Health · doi:10.2105/ajph.2018.304883 · Cited by 734
Supplemental MRI Screening for Women with Extremely Dense Breast Tissue
Bakker, M. F., de Lange, S. V., Pijnappel, R. M., Mann, R. M., Peeters, P. H. M., Monninkhof, E. M., Emaus, M. J., Loo, C. E., Bisschops, R. H. C., Lobbes, M. B. I., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903986 · Cited by 702
Ohuchi, N., Suzuki, A., Sobue, T., Kawai, M., Yamamoto, S., Zheng, Y.-F., Shiono, Y. N., Saito, H., Kuriyama, S., Tohno, E., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00774-6 · Cited by 616
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Kubik, M., et al. (2019) · JAMA · doi:10.1001/jama.2019.10987 · Cited by 467
Self-citationSkaane, P., Bandos, A. I., Eben, E. B., Jebsen, I. N., Krager, M., Haakenaasen, U., Ekseth, U., Izadi, M., Hofvind, S., & Gullien, R. (2014) · Radiology · doi:10.1148/radiol.13131391 · Cited by 332
Plevritis, S. K., Munoz, D., Kurian, A. W., Stout, N. K., Alagoz, O., Near, A. M., Lee, S. J., van den Broek, J. J., Huang, X., Schechter, C. B., et al. (2018) · JAMA · doi:10.1001/jama.2017.19130 · Cited by 302
Self-citationBreast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR
Monticciolo, D. L., Newell, M. S., Moy, L., Lee, C. S., & Destounis, S. V. (2023) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2023.04.002 · Cited by 290
Identifying Women With Dense Breasts at High Risk for Interval Cancer: A Cohort Study
Kerlikowske, K., Zhu, W., Tosteson, A. N. A., Sprague, B. L., Tice, J. A., Lehman, C. D., Miglioretti, D. L., & for the Breast Cancer Surveillance Consortium* (2015) · Annals of Internal Medicine · doi:10.7326/m14-1465 · Cited by 286
Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002158 · Cited by 258
Monticciolo, D. L., Malak, S. F., Friedewald, S. M., Eby, P. R., Newell, M. S., Moy, L., Destounis, S., Leung, J. W. T., Hendrick, R. E., & Smetherman, D. (2021) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2021.04.021 · Cited by 230
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Kubik, M., et al. (2019) · JAMA · doi:10.1001/jama.2019.11885 · Cited by 189
Self-citationConant, E. F., Beaber, E. F., Sprague, B. L., Herschorn, S. D., Weaver, D. L., Onega, T., Tosteson, A. N. A., McCarthy, A. M., Poplack, S. P., Haas, J. S., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3695-1 · Cited by 184
Veenhuizen, S. G. A., de Lange, S. V., Bakker, M. F., Pijnappel, R. M., Mann, R. M., Monninkhof, E. M., Emaus, M. J., de Koekkoek-Doll, P. K., Bisschops, R. H. C., Lobbes, M. B. I., et al. (2021) · Radiology · doi:10.1148/radiol.2021203633 · Cited by 174
The Emergence of the Racial Disparity in U.S. Breast-Cancer Mortality
Jatoi, I., Sung, H., & Jemal, A. (2022) · New England Journal of Medicine · doi:10.1056/nejmp2200244 · Cited by 172
Gierach, G. L., Ichikawa, L., Kerlikowske, K., Brinton, L. A., Farhat, G. N., Vacek, P. M., Weaver, D. L., Schairer, C., Taplin, S. H., & Sherman, M. E. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs327 · Cited by 164
Miglioretti, D. L., Zhu, W., Kerlikowske, K. M., Sprague, B. L., Onega, T., Buist, D. S. M., Henderson, L. M., & Smith, R. A. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3084 · Cited by 113
Price, E. R., Hargreaves, J., Lipson, J. A., Sickles, E. A., Brenner, R. J., Lindfors, K. K., Joe, B. N., Leung, J. W. T., Feig, S. A., Bassett, L. W., et al. (2013) · Radiology · doi:10.1148/radiol.13131217 · Cited by 112
Henderson, J. T., Webber, E. M., Weyrich, M. S., Miller, M. E., & Melnikow, J. A. (2024) · JAMA · doi:10.1001/jama.2023.25844 · Cited by 111
Lee, J. M., Arao, R. F., Sprague, B. L., Kerlikowske, K. M., Lehman, C. D., Smith, R. A., Henderson, L. M., Rauscher, G. H., & Miglioretti, D. L. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.8372 · Cited by 108
Emerson, M. A., Golightly, Y. M., Aiello, A. E., Reeder-Hayes, K. E., Tan, X. M., Maduekwe, U. N., Johnson‐Thompson, M., Olshan, A. F., & Troester, M. A. (2020) · Cancer · doi:10.1002/cncr.33121 · Cited by 105
Time to diagnosis and breast cancer stage by race/ethnicity
Warner, E. T., Tamimi, R. M., Hughes, M. E., Ottesen, R. A., Wong, Y., Edge, S. B., Theriault, R. L., Blayney, D. W., Niland, J. C., Winer, E. P., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2304-1 · Cited by 102
Breast Cancer Surveillance Consortium
National Cancer Institute (2020) · Definitions · doi:10.32388/7oifu8 · Cited by 100
García‐Albéniz, X., Hernán, M. Á., Logan, R. W., Price, M., Armstrong, K., & Hsu, J. (2020) · Annals of Internal Medicine · doi:10.7326/m18-1199 · Cited by 85
Ho, T.-Q. H., Bissell, M. C. S., Kerlikowske, K. M., Hubbard, R. A., Sprague, B. L., Lee, C. I., Tice, J. A., Tosteson, A. N. A., & Miglioretti, D. L. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.2440 · Cited by 85
Lawson, M. B., Bissell, M. C. S., Miglioretti, D. L., Eavey, J., Chapman, C. H., Mandelblatt, J. S., Onega, T., Henderson, L. M., Rauscher, G. H., Kerlikowske, K. M., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.1990 · Cited by 84
The frequency of breast cancer screening
(2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00397-5 · Cited by 78
Mammography screening in African American women: Evaluating the research
Jones, B. A., Patterson, E. A., & Calvocoressi, L. (2002) · Cancer · doi:10.1002/cncr.11022 · Cited by 65
Kerlikowske, K. M., Su, Y., Sprague, B. L., Tosteson, A. N. A., Buist, D. S. M., Onega, T., Henderson, L. M., Alsheik, N. H., Bissell, M. C. S., O’Meara, E. S., et al. (2022) · JAMA · doi:10.1001/jama.2022.7672 · Cited by 64
Hu, X. Y., Walker, M. S., Stepanski, E. J., Kaplan, C. M., Martin, M. Y., Vidal, G. A., Schwartzberg, L. S., & Graetz, I. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.25485 · Cited by 60
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies
Trentham‐Dietz, A., Chapman, C. H., Jayasekera, J. C., Lowry, K. P., Heckman‐Stoddard, B. M., Hampton, J. M., Caswell-Jin, J. L., Gangnon, R. E., Lü, Y., Huang, H., et al. (2024) · JAMA · doi:10.1001/jama.2023.24766 · Cited by 60
Self-citationGoel, N., Westrick, A. C., Bailey, Z., Hernandez, A. E., Balise, R. R., Goldfinger, E., Antoni, M. H., Stoler, J. B., Kesmodel, S. B., & Kobetz, E. N. (2022) · PubMed · doi:10.1097/sla.0000000000005375 · Cited by 58
Selove, R., Kilbourne, B. S., Fadden, M. K., Sanderson, M., Foster, M., Offodile, R. S., Husaini, B. A., Mouton, C. P., & Levine, R. S. (2016) · Women s Health Issues · doi:10.1016/j.whi.2016.09.003 · Cited by 53
Nguyen, K. H., Pasick, R. J., STEWART, S. L., Kerlikowske, K. M., & Karliner, L. (2017) · Cancer · doi:10.1002/cncr.30756 · Cited by 50
Owens, D. K., Whitlock, E. P., Henderson, J. T., Pignone, M. P., Krist, A. H., Bibbins-Domingo, K. B., Curry, S. J., Davidson, K. W., Ebell, M. H., Gillman, M. W., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2531 · Cited by 49
Racial disparities in triple negative breast cancer: toward a causal architecture approach
Siegel, S. D., Brooks, M. M., Lynch, S. M., Sims‐Mourtada, J., Schug, Z. T., & Curriero, F. C. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01533-z · Cited by 49
Fayanju, O. M., Ren, Y., Stashko, I., Power, S., Thornton, M., Marcom, P. K., Hyslop, T., & Hwang, E. S. (2020) · Cancer · doi:10.1002/cncr.33310 · Cited by 45
Lynn, B. C. D., Chernyavskiy, P., Gierach, G. L., & Rosenberg, P. S. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab186 · Cited by 42
McGuinness, J. E., Ueng, W., Trivedi, M. S., Yi, H. S., David, R., Vanegas, A., Vargas, J., Sandoval, R., Kukafka, R., & Crew, K. D. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0009 · Cited by 22
Richman, I. B., Long, J. B., Hoag, J. R., Upneja, A., Hooley, R. J., Xu, X. J., Kunst, N., Aminawung, J. A., Kyanko, K. A., Busch, S. H., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab063 · Cited by 18
Hu, X. Y., Chehal, P. K., Kaplan, C. M., Krukowski, R. A., Lan, R., Stepanski, E. J., Schwartzberg, L. S., Vidal, G. A., & Graetz, I. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.12076 · Cited by 18
Ganguli, I., Keating, N. L., Thakore, N. L., Lii, J., Raza, S., & Pace, L. E. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.7234 · Cited by 18
Cited by
Global patterns and trends in breast cancer incidence and mortality across 185 countries
Kim, J., Harper, A., McCormack, V., Sung, H., Houssami, N., Morgan, E., Mutebi, M., Garvey, G., Soerjomataram, I., & Fidler-Benaoudia, M. M. (2025) · Nature Medicine · doi:10.1038/s41591-025-03502-3 · Cited by 1,163
Metadata
- Authors
- US Preventive Services Task Force, Nicholson, W. K., Silverstein, M., Wong, J. B., Barry, M. J., Chelmow, D., Coker, T. R., Davis, E. M., Jaén, C. R., Krousel-Wood, M., Lee, S., Li, L., Mangione, C. M., Rao, G., Ruiz, J. M., Stevermer, J. J., Tsevat, J., Underwood, S. M., & Wiehe, S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2024-06-11
- Volume
- 331
- Issue
- 22
- Pages
- 1918
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4396509461
- Cited by
- 463
- References
- 48
- FWCI
- 117.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.